Last Updated：2025/12/06
Sentence
臨床試験では、アトルティビマブに用いられるモノクローナル抗体が、他の抗体治療と併用した場合にウイルス量を有意に減少させることが示されました。
Quizzes for review
In the clinical trial, odesivimab demonstrated a significant reduction in viral load when given alongside other antibody therapies.
See correct answer
In the clinical trial, odesivimab demonstrated a significant reduction in viral load when given alongside other antibody therapies.
音声機能が動作しない場合はこちらをご確認ください
Related words
odesivimab
IPA(Pronunciation)
English - English
Word Edit Setting
- Users who have edit permission for words - All Users
- Screen new word creation
- Screen word edits
- Screen word deletion
- Screen the creation of new headword that may be duplicates
- Screen changing entry name
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
Sentence Edit Setting
- Users who have edit permission for sentences - All Users
- Screen sentence deletion
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
Quiz Edit Setting
- Users who have edit permission for quizzes - All Users
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
